Monthly Archives: January 2021
VUMC, Case Western apply artificial intelligence to “customize” oral cancer treatment
Researchers at Vanderbilt University Medical Center and Case Western Reserve University in Cleveland have been awarded a five-year, $3.3 million grant by the National Cancer Institute to apply artificial intelligence (AI) to help customize treatment fo… Continue reading
Discovery Sciences Emerging Scholars Lectures presents UC-Berkeley’s Florentine Rutaganira, Jan. 21
NEW: Frequently asked questions about Tennessee Department of Health’s COVID-19 vaccine plan
Recently, officials with the Tennessee Department of Health announced changes to the state’s COVID vaccine plan. Changes include the opportunity for people age 75 and older, along with educators, to be added to the list of those eligible to be vaccinat… Continue reading
NEW: VUMC to expand COVID-19 vaccine availability to additional groups
Under the direction of the Tennessee Department of Health and Centers for Disease Control and Prevention, Vanderbilt University Medical Center will soon offer COVID-19 vaccine to more groups. Continue reading
UPDATE: Weekly COVID-19 statistics
A snapshot of some of the numbers that help tell the story of COVID-19 at Vanderbilt. Continue reading
Response to: The Pi*MZ Allele in Alpha-1 Antitrypsin Increases Liver-Related Outcomes in a Population-Based Study
Disparities in Preventable Mortality from Colorectal Cancer: are they the result of structural racism?
Clinical pharmacists and patients with inflammatory bowel diseases: are we ready for the multidisciplinary approach?
Zinc Dependent Regulation of ZEB1 and YAP1 Co-activation Promotes EMT Plasticity and Metastasis in Pancreatic Cancer
This study defines a novel ZIP4-miR-373-LATS2-ZEB1/YAP1-ITGA3 signaling pathway that meditates pancreatic cancer metastasis and EMT plasticity. The findings are highly translational to develop new personalized therapy for pancreatic cancer. Continue reading